Virtual Program - RISK ASSESSMENT IN PAH: Implications for Prognosis and Treatment
Posted over 3 years ago
This announcement has 1 attachment:
YOU ARE CORDIALLY INVITED to a disease education discussion:
FOCUS ON RISK ASSESSMENT IN PAH: Implications for Prognosis and Treatment
(Presentation will not include information on commercial products)
Date: Tuesday, October 27, 2020
Time: 6:00 PM Pacific Standard Time
Location: Virtual Program
PRESENTED BY Therese Sargent, MSN, NP ANP, APRN, BC
Cardiovascular Consultants, PHOENIX, AZ
ActelionEvents@guidemarkhealth.com | EVENT CODE: 5021
If you have any questions, please call the Program Coordinator, Kathy Dorman, at 1-303-358-2970, or your Actelion representative, Mary Martina, at 1-602-717-3711